A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency

Loading...
Thumbnail Image

Authors

Van der Westhuizen, Francois H.
Smuts, Izelle
Honey, Engela M.
Louw, Roan
Schoonen, Maryke
Jonck, Lindi-Maryn
Dercksen, Marli

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Neonatal-onset multiple acyl-CoA dehydrogenase deficiency (MADD type I) is an autosomal recessive disorder of the electron transfer flavoprotein function characterized by a severe clinical and biochemical phenotype, including congenital abnormalities with unresponsiveness to riboflavin treatment as distinguishing features. From a retrospective study, relying mainly on metabolic data, we have identified a novel mutation, c.1067G > A (p.Gly356Glu) in exon 8 of ETFDH, in three South African Caucasian MADD patients with the index patient presenting the hallmark features of type I MADD and two patients with compound heterozygous (c.1067G > A + c.1448C > T) mutations presenting with MADD type III. SDS-PAGE western blot confirmed the significant effect of this mutation on ETFDH structural instability. The identification of this novel mutation in three families originating from the South African Afrikaner population is significant to direct screening and strategies for this disease, which amongst the organic acidemias routinely screened for, is relatively frequently observed in this population group.

Description

Keywords

Multiple acyl-CoA dehydrogenase deficiency (MADD), Glutaric aciduria type II (GAII), Metabolic disorder, Electron transfer protein (ETF), Autosomal recessive disorder, Congenital abnormalities, Riboflavin, Organic acidemias

Sustainable Development Goals

Citation

Van der Westhuizen, F.H., Smuts, I., Honey, E. et al. 2018, 'A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency', Journal of the Neurological Sciences, vol. 384, pp. 121-125.